ʻIke Nui
Hoʻokumu ʻia ka phospholipase A2 (Lp-PLA2) pili i ka lipoprotein e nā pūnaewele inflammatory a kaʻahele mua i ka lipoprotein haʻahaʻa haʻahaʻa (LDL) a i kahi liʻiliʻi e pili ana me ka lipoprotein kiʻekiʻe kiʻekiʻe (HDL) i loko o ka plasma kanaka.ʻIke ʻia ʻo LDL oxidation ma ke ʻano he hanana koʻikoʻi i ka pathogenesis o ka atherosclerosis.Ua loaʻa nā kiʻekiʻe Lp-PLA2 kiʻekiʻe i nā pā atherosclerotic a me nā ʻeha ʻeha.
Manaʻo Pair | CLIA (Hopu-Hopu): 1B10-5 ~ 1D2-1 |
Maemae | >95%, hoʻoholo ʻia e SDS-PAGE |
ʻO ka hoʻopololei ʻana | PBS, pH7.4. |
Waihona | E mālama iā ia ma lalo o nā kūlana sterile ma -20 ℃ a -80 ℃ ma ka loaʻa ʻana. Manaʻo e hoʻokaʻawale i ka protein i nā mea liʻiliʻi no ka mālama maikaʻi ʻana. |
inoa mea kūʻai | Cat.ʻAʻole | Klone ID |
Lp-PLA2 | AB0008-1 | 1B10-5 |
AB0008-2 | 1D2-1 | |
AB0008-3 | 1E12-4 |
'Ōlelo Aʻo: Hiki i ka Bioantibody ke hoʻololi i ka nui o kāu pono.
1.Li D , Wei W , Ran X , et al.ʻO ka phospholipase A2 pili i ka Lipoprotein a me nā pilikia o ka maʻi naʻau coronary a me ka hahau ischemic i ka heluna lehulehu: He loiloi ʻōnaehana a me ka meta-analysis [J].Clinica Chimica Acta, 2017, 471:38.
2.Wilensky RL , Macphee CH .Lipoprotein-pili phospholipase A(2) and atherosclerosis.[J].Manaʻo o kēia manawa ma Lipidology, 2009, 20 (5): 415-420.